Guangji Pharmaceutical Company: Controlling shareholder intends to subscribe for no more than 30% of the shares.

Guangji Pharmaceutical Industry Announcement, the controlling shareholder Changjiang Industrial Investment Group Co., Ltd. has committed to subscribe to no more than 94.9367 million shares of A-shares issued by the Company to specific objects in 2026, not exceeding 30% of the total pre-issuance share capital, and the issuance price will not be less than 80% of the average price of the last twenty trading days before the pricing date. The source of the subscription funds is from its own and/or legally raised funds; the shares subscribed by it shall not be transferred within 36 months from the end of the issuance, and the shares obtained through the distribution of stock dividends, the capital reserve capital increase, and other methods are also subject to restrictions on transfer.